Malawi

in page functions
[French]
Malawi
Total population (2017) 18,298,666
Birth cohort (2017) 692,291
Surviving Infants (surviving to 1 year per year, 2017) 656,296
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 43/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 64/1000
World Bank Index, IDA (2015) 3.15
Gross Nation Income (per capita US$, 2015) 340
Co-financing group (2018) Initial self-financing
No. of districts/territories (2016) 28

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Malawi

Type of support

Approvals

2001-2022 (US$)
(29 May 2018)

Commitments

2001-2022 (US$)
(29 May 2018)

Disbursements

2000-2018 (US$)
(29 May 2018)

% Disbursed

(29 May 2018)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021
Total $246,548,578 $301,200,883 $219,812,341
Cash Support (CASHSUPP) $197,000 $197,000 $172,000 87%
Cold Chain Equipment Optimisation Platform (CCEOP) $2,369,630 $4,481,534 $958,895 40%
Health system strengthening (HSS 1) $11,002,375 $11,002,375 $11,002,375 100%
Health system strengthening (HSS 2) N/A
Health system strengthening (HSS 3) $35,259,599 $49,000,000 $7,045,515 20%
HPV (NVS) $2,243,000 $6,172,500
HPV Demo (NVS) $475,773 $475,773 $339,895 71%
HPV MAC (NVS) $9,954,500 N/A
HPV MAC - Op costs (OPC) $733,500 N/A
Immunisation services support (ISS) $1,986,000 $1,986,000 $1,986,000 100%
Injection Safety Devices (NVS) $424,706 $1,084,706 $273,706 64%
Injection safety support (INS) $722,509 $722,509 $722,509 100%
IPV (NVS) $669,464 $669,464 $325,464 49%
Measles (NVS) $866,339 $1,352,839 $641,839 74%
Measles-Rubella (NVS) $6,300,028 $6,300,028 $6,300,028 100%
MR - Operational costs (OPC) $5,030,349 $5,030,349 $5,030,349 100%
Penta (NVS) $90,321,958 $92,577,958 $90,532,091 100%
Pneumo (NVS) $67,869,522 $83,360,022 $73,986,880 109%
Product Switch Grant (PSG) $182,289 $182,289 $182,289 100%
Rotavirus (NVS) $17,349,048 $22,638,548 $17,708,017 102%
Vaccine Introduction Grant (VIG) $3,278,989 $3,278,989 $2,604,489 79%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Malawi DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2016)

Grade of confidence


N/A
DTP3 - Official country estimates (2016) 84%
M:F sex ratio at birth (2017) 1.03
Household survey: DTP3 coverage for male (2013) 92.30%
Household survey: DTP3 coverage for female (2013) 92.90%
Household survey: Last DTP3 survey (2013) 93%
% districts achieving > 80% DTP3 coverage (2016) 68%
% districts achieving < 50% DTP3 coverage (2016) 0%
MCV WHO/UNICEF estimates (2016) 81%

Breakdown of support

Non-vaccine support Vaccine support
14% 86%
$29,704,421 $190,107,920

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Malawi

07 May 2018

Zambian children

Largest cholera vaccine drive in history to target spike in outbreaks

Two million people in five African countries to be protected against cholera.

02 May 2018

HPV vaccine's introduction into Zimbabwe's routine immunisation programme

Cervical cancer vaccine introduced in Zimbabwe

800,000 girls to be protected against disease following introduction of HPV vaccine.

03 April 2018

Typhoid vaccination in Nepal

New typhoid vaccine to receive Gavi support

Gavi has earmarked US$ 85 million to fund the introduction of the vaccine in the world’s poorest countries.

close icon

modal window here